Proton Beam Therapy For Glioblastoma

Cancerous cells are particularly vulnerable to attacks on dna.

Proton beam therapy for glioblastoma.

This lessens the chance of damage to surrounding normal brain tissue. Radiation therapy is the same for any brain tumor. Most patients undergoing radiation therapy for glioblastoma receive photon based radiation therapy such as intensity modulated radiotherapy imrt. There are also other new discoveries in adult and childhood brain cancer research and treatment.

Proton therapy is a type of external beam radiotherapy that uses ionizing radiation in proton therapy medical personnel use a particle accelerator to target a tumor with a beam of protons. Twenty three of 81 gbm patients who met the eligible criteria and consented to the protocol were treated with x ray radiation therapy 50 4 gy in 28 fractions in t2 high areas and proton beam therapy 46 2 gye in 28 fractions in gadolinium enhanced volumes 6 hours after x ray radiation therapy concurrent with nimustine. It is used to help reduce the risk of long term side effects that can sometimes develop after standard radiotherapy. Proton therapy provides pinpoint focusing of the radiation beam to the tumor.

Proton beam therapy offers an alternative. A ground breaking clinical trial is treating glioblastoma with intensity modulated proton therapy impt. These charged particles damage the dna of cells ultimately killing them by stopping their reproduction and thereby eliminating the tumor. As a result doctors often reduce the optimal x ray radiation dose required to kill cancer cells.

Chemotherapy uses drugs to stop the growth of cancer cells. Proton beam therapy is only suitable for a small number of people. Proton beam therapy is a type of external beam radiotherapy. Proton therapy is a type of radiation often used for patients with glioblastoma.

Glioblastoma multiforme is one of the toughest brain tumors to treat and also is one of the most aggressive. Twenty three of 81 gbm patients who met the eligible criteria and consented to the protocol were treated with x ray radiation therapy 50 4 gy in 28 fractions in t2 high areas and proton beam therapy 46 2 gye in 28 fractions in gadolinium enhanced volumes 6 hours after x ray radiation therapy concurrent with nimustine hydrochloride or temozolomide.